ZNF703 acts as an oncogene that promotes progression in gastric cancer | Zendy

GongLi Yang | Zendy; Feng Ma | Zendy; Muxiao Zhong | Zendy; Lin Fang | Zendy; Yao Peng | Zendy; Xiaoming Xin | Zendy; Jietao Zhong | Zendy; Fangfang Yuan | Zendy; Hongxiang Gu | Zendy; Wei Zhu | Zendy; Yali Zhang | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

ZNF703 acts as an oncogene that promotes progression in gastric cancer

Author(s) -

GongLi Yang,

Feng Ma,

Muxiao Zhong,

Lin Fang,

Yao Peng,

Xiaoming Xin,

Jietao Zhong,

Fangfang Yuan,

Hongxiang Gu,

Wei Zhu,

Yali Zhang

Publication year - 2014

Publication title -

oncology reports

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.094

H-Index - 96

eISSN - 1791-2431

pISSN - 1021-335X

DOI - 10.3892/or.2014.2997

Subject(s) - oncogene , cancer , cancer research , gene silencing , oncogene proteins , biology , metastasis , cell cycle , gene , regulation of gene expression , genetics

ZNF703, a member of the NET/Nlz family of zinc finger transcription factors, contributes to aspects of developmental growth and patterning across evolutionarily diverse species. ZNF703 has been identified as a novel oncogene in human breast cancer. In the present study, we investigated the expression of ZNF703 in gastric carcinoma and attempted to determine, using cell line models, its biological actions. Using immunohistochemistry, we analyzed the ZNF703 protein expression in 120 clinicopathologically characterized gastric cancer cases. Using RNA interference, we investigated the effects of ZNF703 depletion on tumor proliferation and metastasis in vitro. We found that ZNF703 was overexpressed in invasive gastric carcinoma tissues, and its expression levels were closely correlated with the depth of invasion, node metastasis and venous invasion. RNA interference-mediated silencing of the ZNF703 gene in SGC7901 cells inhibited cell proliferation and migration significantly. The results showed that ZNF703 acts as a gastric cancer oncogene and should be considered a therapeutic target for metastatic gastric cancer.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research